Market Overview

Charles River Laboratories International, Inc. (NYSE: CRL)

229.26 -0.97 (-0.42%)

Earnings

QuarterPriorEstimateActualSurprise
Q2 2021
Pre-Market
EPS:
REV:




Q1 2021
Pre-Market
EPS:
REV:
1.84
707.059M



Q4 2020
Pre-Market
EPS:
REV:
2.01
691.138M



Q3 2020
Pre-Market
EPS:
REV:
1.69
667.951M
1.8
716.36M


Q2 2020
Pre-Market
EPS:
REV:
1.63
657.568M
1.26
641.63M
1.58
682.584M
25.4%
6.38%
Q1 2020
Pre-Market
EPS:
REV:
1.4
604.569M
1.47
691.09M
1.84
707.059M
25.17%
2.31%
Q4 2019
Pre-Market
EPS:
REV:
1.49
601.53M
1.83
685.31M
2.01
691.138M
9.84%
0.85%
Q3 2019
Pre-Market
EPS:
REV:
1.53
585.295M
1.63
672.74M
1.69
667.951M
3.68%
-0.71%
Q2 2019
Pre-Market
EPS:
REV:
1.62
585.301M
1.55
662.51M
1.63
657.568M
5.16%
-0.75%
Q1 2019
Pre-Market
EPS:
REV:
1.38
493.97M
1.38
595.66M
1.4
604.569M
1.45%
1.5%

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!